Nan Fung Trinity’s Climb Bio CLYM Stock Holding History

Nan Fung Trinity’s Portfolio CLYM Stock Details CLYM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.7M	Sell	360,654 -59,863	-14%	-$618K	0.46%	49
2026 Q1	$2.88M	Sell	420,517 -43,137	-9%	-$249K	0.32%	55
2025 Q4	$1.85M	Hold	463,654	–	–	0.15%	74
2025 Q3	$932K	Hold	463,654	–	–	0.09%	67
2025 Q2	$575K	Buy	+463,654	New	+$577K	0.07%	57

Other funds holding CLYM

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

FFO

Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

EWA

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

Nan Fung Trinity's CLYM Position: Q2 2026 in Review

Nan Fung Trinity reduced its Climb Bio (CLYM) stake by 14% in Q2 2026, selling an estimated $618K and leaving 360,654 shares worth $4.7M. The position accounts for 0.46% of the portfolio, ranked #49.

Nan Fung Trinity first reported a position in CLYM in Q2 2025 and has held it in 5 quarters since. 5 funds tracked by Wall St. Rank hold CLYM as of Q2 2026.

Nan Fung Trinity held 360,654 shares of Climb Bio worth $4.7M as of Q2 2026.
Nan Fung Trinity sold 59,863 Climb Bio shares in Q2 2026, an estimated $618K.
Climb Bio made up 0.46% of Nan Fung Trinity's portfolio in Q2 2026, its #49 holding.
Nan Fung Trinity first reported a position in Climb Bio in Q2 2025 and has held it in 5 quarters since.
5 funds tracked by Wall St. Rank held Climb Bio as of Q2 2026.

Based on Nan Fung Trinity's 13F filing for Q2 2026, filed 24 Jul 2026.